Literature DB >> 20451282

Metabolic syndrome and liver transplantation: a review and guide to management.

Kymberly D S Watt1, Michael R Charlton.   

Abstract

Metabolic syndrome is common among liver transplant recipients before and after transplantation. The components of metabolic syndrome are often exacerbated in the post-transplant period by transplant specific factors, such as immunosuppression, and are strong predictors of patient morbidity and mortality. Many aspects of the metabolic syndrome are modifiable. Early recognition, prevention and treatment of post-transplant hypertension, obesity, dyslipidemia and diabetes may impact long-term post-transplant survival. Further study into the prevention and management of these issues in the transplant patient are needed. Copyright 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20451282     DOI: 10.1016/j.jhep.2010.01.040

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  36 in total

Review 1.  Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review.

Authors:  Emily Rothbaum Perito; Audrey Lau; Sue Rhee; John P Roberts; Philip Rosenthal
Journal:  Liver Transpl       Date:  2012-09       Impact factor: 5.799

2.  Prediabetes in Pediatric Recipients of Liver Transplant: Mechanism and Risk Factors.

Authors:  Emily R Perito; Robert H Lustig; Philip Rosenthal
Journal:  J Pediatr       Date:  2016-12-29       Impact factor: 4.406

3.  Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation.

Authors:  Mario Reis Alvares-da-Silva; Claudia Pinto Marques Souza de Oliveira; José Tadeu Stefano; Hermes V Barbeiro; Denise Barbeiro; Francisco G Soriano; Alberto Queiroz Farias; Flair José Carrilho; Luiz Augusto Carneiro D'Albuquerque
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 4.  NAFLD and liver transplantation: Current burden and expected challenges.

Authors:  Raluca Pais; A Sidney Barritt; Yvon Calmus; Olivier Scatton; Thomas Runge; Pascal Lebray; Thierry Poynard; Vlad Ratziu; Filomena Conti
Journal:  J Hepatol       Date:  2016-07-30       Impact factor: 25.083

5.  Are We Ready for Bariatric Surgery in a Liver Transplant Program? A Meta-Analysis.

Authors:  Víctor Lopez-Lopez; Juan José Ruiz-Manzanera; Dilmurodjon Eshmuminov; Kuno Lehmann; Marcel Schneider; Markus von der Groeben; David Ruiz de Angulo; Ursula Gajownik; Jose Antonio Pons; Francisco Sánchez-Bueno; Ricardo Robles-Campos; Pablo Ramírez-Romero
Journal:  Obes Surg       Date:  2020-11-23       Impact factor: 4.129

Review 6.  Liver transplantation and non-alcoholic fatty liver disease.

Authors:  Petros Zezos; Eberhard L Renner
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

7.  Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-First report from India.

Authors:  Suneed Kumar; Nidhi Khandelwal; Abhaya Kumar; Kapildev Yadav; Swapnil Sharma; Shailesh Sable; Ashutosh Chauhan; Sorabh Kapoor; Vibha Varma; Jaydeep Palep; Vinay Kumaran
Journal:  Indian J Gastroenterol       Date:  2017-05-31

Review 8.  Metabolic complications in liver transplant recipients.

Authors:  Miguel Jiménez-Pérez; Rocío González-Grande; Edith Omonte Guzmán; Víctor Amo Trillo; Juan Miguel Rodrigo López
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

9.  Liver transplantation in adults: Choosing the appropriate timing.

Authors:  Maria Siciliano; Lucia Parlati; Federica Maldarelli; Massimo Rossi; Stefano Ginanni Corradini
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-08-06

Review 10.  Liver transplantation in alcoholic liver disease current status and controversies.

Authors:  Ashwani K Singal; Khushdeep S Chaha; Khalid Rasheed; Bhupinderjit S Anand
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.